FDA
label_change
· 2015-09-01
FDA Approved: IMODIUM MULTI-SYMPTOM RELIEF — Supplemental Application (Kenvue Brands LLC)
Summary
FDA approved a supplemental application for Imodium Multi-Symptom Relief (loperamide hydrochloride and dimethicone) to expand its labeling for multi-symptom rel…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE)